P493 Do antiTNF or Ustekinumab trough levels correlate with joint extraintestinal manifestations activity in Inflammatory bowel disease patients?
Madero Velázquez, L, Zapater, P, Mira, C, Jovani, V, Andrés, M, Aguas, M, Vicens, E, Barreiro-de Acosta, M, Pérez-Pampín, E, Porto-Silva, M, Zabana, Y, Pujol, M, Herreros, B, Ojeda, A, Noguera, J R, Rainieri, L, Bernal, L, Belen, O, Moreno, V, Cameo, J, Sempere, L, Más-Serrano, P, Gutierrez Casbas, A
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article